Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2025 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2025 Earnings Call Transcript November 12, 2025

Autolus Therapeutics plc misses on earnings expectations. Reported EPS is $-0.29728 EPS, expectations were $-0.23.

Operator: Good day. Thank you for standing by.

Amanda Cray: Welcome to Autolus Therapeutics plc Third Quarter 2025 Financial Results Governance Call. At this time, participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a...